Skip to main content
. 2018 Oct 1;2018(10):CD001059. doi: 10.1002/14651858.CD001059.pub5

Li 2000.

Methods "Patients were divided into 3 groups."
Participants Women recruited at the outpatient clinic and labour ward of the First Afifliated Hospital of Xi’an Medical University between Aug 1996 to Dec 1998.
High‐risk women with a predisposition to PIH.  Participants were required to be at 20‐24 weeks' gestation when entering the study, with a BMI index of < 24,  and an arterial pressure of < 11.3 kPa. Study states only that participants were "selected from our hospital outpatient clinic and labour ward".
Interventions The first group (n = 29) received a daily dose of 600 mg of Calictrate‐D, the second group (n = 29) received 1200 mg if Calcitrate‐D daily, and the third group (n = 30), the control group, received nothing. From 20‐24 weeks till birth
Outcomes Hypertension; biochemical studies
Notes The outpatient clinic and labour ward of the First Afifliated Hospital of Xi’an Medical University.
Aug 1996 to Dec 1998. No information on consent or ethical approval
Source of funding: not clear (original article not in English).
CoI: not clear.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not reported
Allocation concealment (selection bias) Unclear risk Not reported
Blinding of participants and personnel (performance bias) 
 All outcomes High risk No placebo
Blinding of outcome assessment (detection bias) 
 All outcomes High risk No placebo
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Loss to follow‐up not reported
Selective reporting (reporting bias) Unclear risk No information
Other bias High risk Methods not reported